micro-community-banner
 
  • Saved

Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature - PubMed

Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34079795/

This study demonstrated that CIFs further contribute to the observed heterogeneity of DLBCL, and molecular classification and a risk signature based on CIFs are both promising tools for prognostic stratification,...

  • 4yr
    Eye opening article elaborating cachexia factors and importance in dlbcl prognosis
  • Saved

Value of total lesion glycolysis and cell-of-origin subtypes for prognostic stratification of diffuse large B-cell lymphoma patients - PubMed

Value of total lesion glycolysis and cell-of-origin subtypes for prognostic stratification of diffuse large B-cell lymphoma patients - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34079720/

The TLG, cell-of-origin subtypes, and NCCN-IPI are independent prognostic survival factors in DLBCL patients. Moreover, the revised risk model composed of the number of risk factors (high TLG, non-GCB, and...

  • 4yr
    This is an interesting retrospective study demonstrating the prognostic value of pet/ct total lesions glycolysis plus disease subtype plus nccn ipi with development of a new score for outcome prediction.
  • Saved

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib - PubMed

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34079282/

Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma, and the most frequent histological type is diffuse large B-cell lymphoma (DLBCL). Bruton's tyrosine kinase inhibitor...

  • 4yr
    Key Points • In the current case report, investigators documented the successful treatment of a 53-year-old patient with refractory primary central nervous system lymphoma (PCNSL) using the small molecule inhibitor zanubrutinib. • Show More
  • 4yr
    Clinically useful article demonstrating that a next gen btki can penetrate cns and treat pcns....
  • Saved

CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance - PubMed

CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34079334/

1 Department of Stomatology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, People's Republic of China. 2 Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,...

  • 4yr
    Cd24 as measured by rna expression seems to correlate positively with outcome in abc subset of DLBCL ...further work should be confirmatory and perhaps identify a readily available test
  • Saved

Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma - PubMed

Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34075009/

doi: 10.1097/MNM.0000000000001447. Online ahead of print. 1 Department of Nuclear Medicine, University of Health Sciences, Ankara City Hospital Department of Medical Informatics, Middle East Technical University, Informatics Institute Department of...

  • 4yr
    Fascinating article showing that suvmax and textural heterogeneity of the tumor are responsible for unsatisfactory frontline treatment results. The study is rather small but if confirmed in a larger Show More